Skip to main content
. 2007 May 11;133(9):599–611. doi: 10.1007/s00432-007-0206-0

Table 8.

Correlating the glycan:sulfotransferase activities with the gastric tumor types

Gastric tumor Specimen Stage of cancer Patient status α1,2-FT Activity decrease (%) Gal3Sulfo-T2 Gal3Sulto-T4 GlcNAc6SulfoT
Signet ring cell carcinoma–Krukenberg tumor
 Poorly differentiated 7741 D (E) 10 60.7 (75.9) 49.1 (14.4) 43.8 (1.3)
7405 3A D (E) 40 329.0 (156.7) 91.4 (7.1) 53.7 (2.8)
11868 3A D (NE) 40 208.1 (20.6) 111.0 (61.7) 13.6 (7.6)
 Moderately differentiated 11954 2 D (E) 40 2.6 (26.0) 0.5 (5.0) 0.7 (7.0)
Adenocarcinoma
 Poorly differentiated 7323 3A A (UN) (Increase 5.6 fold) 1.4 (14.0) 12.3 (61.5) 86.3 (37.5)
7570 3A D (UN) 90 11.7 (10.6) 75.8 (2.7) 49.8 (1.6)
9529 1B D (NE) 80 2.6 (1.9) 34.3 (5.1) 3.3 (0.6)
11847 2 A (NE) (Increase 0.9 fold) 2.1 (7.0 59.6 (149.0) 5.2 (2.7)
 Moderately differentiated 11681 3A A (NE) 70 2.7 (2.1) 2.3 (3.3) 4.1 (1.4)
12015 1B A (NE) 40 3.3 (8.3) 16.8 (2.4) 15.3 (8.1)
Litinis Plastica
 Poorly differentiated 7532 4 D (E) 2.3 56.2 25.7
Non-epithelial Stromal Sarcoma
 Poorly differentiated: 11577 D (UN) 1.1 4.6 1.3

The values in parentheses are the fold of activity in tumor as compared to that of non-tumor specimen from the same patient

D Dead, E evidence of cancer; NE no evidence of cancer; UN unknown